The United Kingdom will offer an alternative vaccine to AstraZeneca for those under 30 years of age

Almost two-thirds of the 79 cases of thrombi detected so far in the United Kingdom correspond to women The Regulatory Agency for Medicines and Health Products United Kingdom (MHRA, for its acronym in English) has concluded that the possible appearance of thrombi in people immunized against COVID-19 with vaccine AstraZeneca, should be offered an alternative drug to those who are less than 30 years old. The regulator has estimated 79 cases of thrombi registered until the end of March in vaccinated people, 19 of which ended in death, reports the …